Methyl 2-bromoisovalerate,
26330-51-8,
methyl 2-bromo-3-methylbutanoate,
Methyl 2-bromo-3-methylbutyrate,
Butanoic acid, 2-bromo-3-methyl-, methyl ester,
methyl2-bromoisovalerate,
NSC21975,
AC1L5GIS,
AC1Q41NH,
AC1Q244P,
SCHEMBL1459718,
Jsp005179,
CTK4F7673,
KS-00000GKG,
DTXSID40281558,
CKDTYRDFEIGXNO-UHFFFAOYSA-N,
METHYL 2-BROMOISOVALERATE?,
ANW-50046,
MFCD00798412,
NSC-21975,
AKOS006229761,
alpha-Bromoisovaleric acid methyl ester,
GS-3331,
RP25346,
BR-46741,
Q133,
SC-16269,
2-Bromo-3-methylbutyric acid methyl ester,
AB0005964,
DB-007651,
TR-032372,
4CH-007458,
AM20090325,
CS-0030485,
FT-0081293,
FT-0651089,
ST24030945,
EN300-28731,
Butanoic acid,2-bromo-3-methyl-, methyl ester,
S-2827,
330M518,
I14-8782,
J-016385,
J-521956,
Methyl 2-broMoisovalerate inverted exclamation mark inverted exclamation mark,
C6H11BrO2,
Methyl2-bromo-3-methylbutanoate,
AR-1J6628,
CID228837,
1-[(1-Pyrrolidinylcarbonyl)methyl]-4-(3,4,5-trimethoxycinnamoyl)piperazine maleate,
31828-74-7,